Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
FOLFIRI Chemotherapy: What Cancer Patients Need to Know
FOLFIRI Chemotherapy: What Cancer Patients Need to Know. Learn how the FOLFIRI chemotherapy regimen works, its most common side effects, how to reduce toxicity with evidence-based integrative therapies, and what to expect during treatment.
If your oncologist has recommended FOLFIRI, you’re probably wondering what the treatment involves, why it’s used, and what side effects to expect.
Like FOLFOX, FOLFIRI isn’t a single chemotherapy drug—it’s a combination of medications designed to attack cancer cells in different ways. It is one of the standard chemotherapy regimens for colorectal cancer and is also used in several gastrointestinal cancers.
While FOLFIRI can be highly effective, it also causes predictable side effects. The encouraging news is that many of these toxicities can be reduced through evidence-based supportive care, nutrition, lifestyle changes, and selected supplements.
This guide explains:
- What FOLFIRI is
- Which cancers it treats
- The most common side effects
- Evidence-based ways to reduce toxicity
- Questions to ask your oncologist
- Resources for additional help
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Before beginning Folfiri therapy, consider:
Scroll down the page and post a question or a comment if there’s anything you’d like to know about Folfox for Cancer..
Good luck,
David Emerson
Folfiri chemotherapy
What Does FOLFIRI Stand For?
| Letter | Drug | Purpose |
|---|---|---|
| FOL | Folinic Acid (Leucovorin) | Enhances 5-FU activity |
| F | Fluorouracil (5-FU) | Stops cancer cell division |
| IRI | Irinotecan | Damages DNA during cell division |
Unlike FOLFOX, FOLFIRI replaces oxaliplatin with irinotecan.
That single substitution changes the side effect profile considerably.
Which Cancers Are Treated with FOLFIRI?
FOLFIRI is commonly used for:
- Metastatic colorectal cancer
- Colon cancer
- Rectal cancer
- Occasionally gastric cancer
- Selected pancreatic cancer protocols
- Other gastrointestinal cancers
It is frequently combined with targeted therapies including:
- Bevacizumab (Avastin)
- Cetuximab (Erbitux)
- Panitumumab (Vectibix)
How Is FOLFIRI Given?
Typical schedule:
- Every 14 days
- IV irinotecan
- IV leucovorin
- IV 5-FU bolus (sometimes omitted)
- 46-hour 5-FU infusion pump
Most patients receive:
- 8–12 cycles
- Sometimes longer in metastatic disease depending on response.
Common Side Effects of FOLFIRI
| Side Effect | Frequency | Typical Timing |
|---|---|---|
| Diarrhea | Very common | Early or delayed |
| Nausea | Common | First several days |
| Fatigue | Very common | Entire cycle |
| Low white blood cells | Common | 7–10 days |
| Mouth sores | Common | Days 5–10 |
| Hair thinning | Moderate | Several weeks |
| Appetite loss | Common | Early |
| Weight loss | Possible | Ongoing |
| Infection risk | Increased | Throughout treatment |
Unlike FOLFOX, neuropathy is much less common.
Instead, diarrhea becomes the major concern.
Understanding Irinotecan Diarrhea
One unique aspect of FOLFIRI is that it can cause two completely different types of diarrhea.
Early diarrhea
Occurs:
- During infusion
- Within 24 hours
Usually accompanied by:
- Sweating
- Abdominal cramping
- Tearing
- Runny nose
This is caused by excess acetylcholine and is usually treated with atropine.
Delayed diarrhea
Occurs:
- Two to ten days later
This form can become severe and may cause:
- Dehydration
- Electrolyte loss
- Hospitalization
Patients should contact their oncology team immediately if diarrhea becomes severe or persistent.
Integrative Therapies That May Reduce Side Effects
Fatigue
Evidence supports:
- Walking
- Resistance exercise
- Protein optimization
- Sleep hygiene
- Mindfulness
- Yoga
Evidence: ★★★★★
Diarrhea
Evidence supports:
- Aggressive hydration
- Oral rehydration solutions
- Soluble fiber (when appropriate)
- Early use of loperamide as directed
- Careful electrolyte replacement
Evidence: ★★★★☆
Gut Microbiome Support
Research suggests chemotherapy alters intestinal bacteria.
Strategies being studied include:
- High-fiber diets (when tolerated)
- Fermented foods
- Selected probiotics (only with oncology approval)
- Prebiotic foods
Evidence: ★★★☆☆
Exercise
Regular exercise during chemotherapy has been associated with:
- Less fatigue
- Better physical function
- Improved quality of life
- Lower treatment interruptions
Evidence: ★★★★★
Nutrition
Patients who maintain:
- adequate calories
- protein intake
- hydration
generally tolerate chemotherapy better.
Mediterranean-style eating patterns are associated with improved overall health during cancer treatment.
Evidence: ★★★★☆
Evidence Rating
| Therapy | Evidence |
|---|---|
| Exercise | ★★★★★ |
| Hydration | ★★★★★ |
| Nutrition | ★★★★☆ |
| Oral rehydration therapy | ★★★★★ |
| Mindfulness | ★★★★☆ |
| Sleep optimization | ★★★★☆ |
| Gut microbiome support | ★★★☆☆ |
| Probiotics | ★★☆☆☆ (individualized) |
When Should You Call Your Oncologist?
Call immediately if you develop:
- Fever ≥100.4°F (38°C)
- Severe diarrhea
- Bloody diarrhea
- Inability to keep fluids down
- Signs of dehydration
- Severe abdominal pain
- Confusion
- Shortness of breath
Questions to Ask Before Starting FOLFIRI
- Why are you recommending FOLFIRI instead of FOLFOX?
- Will I also receive Avastin or another targeted therapy?
- Am I at high risk for severe diarrhea?
- Should I undergo UGT1A1 genetic testing?
- Which symptoms require an emergency call?
- What supplements should I avoid?
- What can I do to reduce fatigue?
- Should I meet with a dietitian before treatment begins?
To learn more:
This article would link naturally to many existing PeopleBeatingCancer resources, including:
Chemotherapy
Side Effects
- Chemotherapy-Induced Anemia
- Strengthen Blood Counts Naturally
- Hand-Foot Syndrome
- Electrolyte Disorders in Cancer Survivors
- Chemotherapy-Induced Nephrotoxicity
- Chemotherapy-Induced Vascular Dysfunction
- Chemotherapy Fatigue
- Chemotherapy-Induced Peripheral Neuropathy (contrast with FOLFOX)
Integrative Therapies
- Integrative Oncology
- Complementary Cancer Therapies
- Anti-Inflammatory Diet
- Exercise During Chemotherapy
- Gut Microbiome and Cancer
Key Research
- André T, et al. Irinotecan-based chemotherapy in metastatic colorectal cancer. Journal of Clinical Oncology.
- Benson AB, et al. NCCN Guidelines: Colon Cancer.
- Van Cutsem E, et al. ESMO Clinical Practice Guidelines for metastatic colorectal cancer.
- ASCO Guidelines on Management of Chemotherapy Toxicities.
- Pattern-of-care data demonstrating FOLFOX as the most common first-line regimen and FOLFIRI as the most common second-line regimen in metastatic colorectal cancer.